Multifaceted role of Rho, Rac, Cdc42 and Ras in intercellular junctions, lessons from toxins  by Popoff, Michel R. & Geny, Blandine
Biochimica et Biophysica Acta 1788 (2009) 797–812
Contents lists available at ScienceDirect
Biochimica et Biophysica Acta
j ourna l homepage: www.e lsev ie r.com/ locate /bbamemReview
Multifaceted role of Rho, Rac, Cdc42 and Ras in intercellular junctions, lessons
from toxins
Michel R. Popoff ⁎, Blandine Geny
Institut Pasteur, Unité des Bactéries anaérobies et Toxines, 28 rue du Dr Roux, 75724 Paris cedex151, France⁎ Corresponding author.
E-mail address: mpopoff@pasteur.fr (M.R. Popoff).
0005-2736/$ – see front matter © 2009 Elsevier B.V. A
doi:10.1016/j.bbamem.2009.01.011a b s t r a c ta r t i c l e i n f oArticle history: Tight junctions (TJs) and ad
Received 27 March 2008
Received in revised form 20 January 2009
Accepted 22 January 2009
Available online 31 January 2009
Keywords:
Adherens junction
Tight junction
Rho-GTPase
Ras
Toxinherens junctions (AJs) are dynamic structures linked to the actin cytoskeleton,
which control the paracellular permeability of epithelial and endothelial barriers. TJs and AJs are strictly
regulated in a spatio-temporal manner by a complex signaling network, including Rho/Ras-GTPases, which
have a pivotal role. Rho preferentially regulates TJs by controlling the contraction of apical acto-myosin
ﬁlaments, whereas Rac/Cdc42 mainly coordinate the assembly–disassembly of AJ components. However, a
subtle balance of Rho/Ras-GTPase activity and interplay between these molecules is required to maintain an
optimal organization and function of TJs and AJs. Conversely, integrity of intercellular junctions generates
signals through Rho-GTPases, which are involved in the regulation of multiple cellular processes. Rho/Ras-
GTPases and the control of intercellular junctions are the target of various bacterial toxins responsible for
severe diseases in man and animals, and are part of their mechanism of action. This review focuses on the
regulation of TJs and AJs by Rho/Ras-GTPases through molecular approaches and bacterial toxins.
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In multicellular organisms, cells come into contact and interact
speciﬁcally with other cells, and are organized in tissues and organs.
Epithelial and endothelial tissues are of a particular importance, since
they constitute barriers controlling the passage of water, solutes, andll rights reserved.cells from one compartment to another. In addition, epithelia such as
those of the respiratory or gastro-intestinal tract, form the interface
between the external and internal environments of the organism, and
thereby constitute the ﬁrst line of defense against invasive pathogens or
toxins. For example, the intestinal epitheliumrepresents the largest area
of the body in contact with the environment. Its main function is the
absorption of nutrients, but it also regulates water and ion homeostasis,
and assures a protective barrier against the resident microﬂora and
pathogens. Epithelial and endothelial cells are connected by two main
types of intercellular junctions, tight junctions (TJ) and adherens (AJ)
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intercellular spaces. In epithelial cell barriers, TJs and AJs are well
deﬁned and are differentially distributed along the intercellular cleft. TJs
form an apical rim, whereas AJs are localized basolaterally below TJs. In
contrast, in endothelia, TJs and AJs have no distinct spatial localization,
but are intermingled [1]. It is noteworthy that TJs and AJs are
intracellularly linked to the actin cytoskeleton. TJs and AJs are highly
regulateddynamic structures,whosepivotal regulatorypartners, among
many other regulators, include Rho family GTPases, which control both
the actin cytoskeleton and the integrity of intercellular junctions, and
Ras involved in cell proliferation and differentiation. Moreover, inter-
cellular junction components and regulatory molecules such as Rho-
and Ras-GTPases are a target for various pathogens and toxins, aswell as
a target for mutations or dysregulation leading to tumor initiation.
Indeed, mutations of Ras proteins or dysregulation of Rho-GTPase
signaling contribute to the initiation and progression of numerous types
of cancer [2–5]. Rho-GTPases have an effect on the invasion and
migration of metastatic cells through remodeling of the actin cytoske-
leton and subsequent disassembly of intercellular junctions [32]. Loss of
cell–cell contacts is a major step in cancer progression.
After a succinct description of TJ and AJ organization (for more
details see reviews: [1, 6–15]), and Rho/Ras-GTPases, this review
focuses on the role of Rho-GTPases and Ras in the regulation of mature
junctions and barrier function, based on works using genetic mutants
and bacterial toxins.
2. Tight junctions
TJs are localized at themost apical part of epithelial cells, and form a
network of close contacts (TJ strands) between membranes of adjacentTable 1
Main tight junction (TJ) and adherens (AJ) junction components, binding partners and pot
Protein Protein type Binding partners
Tight junctions
Occludin Transmembrane protein ZO-1, -2, -3, JAM-A, cing
Claudins Transmembrane proteins ZO-1, -2, -3, PATJ, MUPP-
JAMs, CAR, ESAM Transmembrane proteins Occludin, ZO-1, cingulin,
MUPP-1, AF-6/afadin
Tricellulin Transmembrane protein
ZO-1 Cytoplasmic adaptor protein Occludin, claudins, JAMs
cingulin, F-actin, α-caten
ZO-2, ZO-3 Cytoplasmic adaptor protein Occludin, claudins, ZO-1,
cingulin, α-catenin
MUPP-1 Cytoplasmic adaptor protein Claudins, JAMs, CAR
PATJ Cytoplasmic adaptor protein
Cingulin Cytoplasmic adaptor protein ZO-1, -2, -3, JAM, F-actin
PAR-6 Cytoplasmic adaptor protein PAR-3, PKC, Cdc42,
AF-6/afadin Cytoplasmic adaptor protein ZO-1, Ras, F-actin
PILT, JEAP Cytoplasmic adaptor protein
Adherens junctions
Cadherins Transmembrane protein Cadherin, β-catenin, p12
plakoglobin
α-catenin Cytoplasmic adaptor protein β-catenin, F-actin, ZO-1,
formin-1, afadin, Zyxin, S
α-actinin, vinculin
β-catenin Cytoplasmic adaptor protein α-catenin, p120-catenin,
IQGAP, fascin, PI3-kinase
p120-catenin Cytoplasmic adaptor protein E-cadherin, β-catenin, VA
Plakoglobin Cytoplasmic adaptor protein α-catenin, cadherin, des
desmoglein, desmoplakin
Nectin Transmembrane protein Nectin, afadin, PAR-3
Afadin Cytoplasmic adaptor protein Nectin, α-catenin, F-actin
proﬁlin, Bcr, c-Src
Vezatin Transmembrane protein Myosin VIIA, cadherin–c
EPLIN Cytoplasmic adaptor protein F-actin, α-catenin
The horizontal bars of the submitted table have been omitted. Please insert a space line inscells. TJs control the paracellular transport of ions, water, solutes and
cells, and in addition they constitute a fence separating apical and
basolateral membrane proteins. TJs are formed of two types of
membrane proteins, occludin and claudins, which are associated with
cytoplasmic proteins, linking TJs to the actin cytoskeleton (Table 1).
Occludin (65 kDa, two isoforms) contain four transmembrane
domains and two extracellular loops. The C-terminal domain, localized
in the cytoplasm, directly binds toZO-1 (zonula occludens),which in turn
associateswith the apical actin rim. This region is rich in phosphorylation
sites (tyrosine, serine, and threonine) which can be modiﬁed by kinases
(c-Yes, protein kinase C) or phosphatases (PP2A). Non-phosphorylated
occludin is distributed on basolateral membrane and in cytoplasmic
vesicles, whereas phosphorylated occludin is localized in TJs, leading to a
decreased paracellular permeability [12,13,16].
Claudins (18–27 kDa; 24 isoforms) like occludin, are tetraspan
proteins with two extracellular loops and a C-terminal cytoplasmic
domain, which binds through PDZ (Post synaptic density protein,
Drosophila disc large tumor suppressor, Zonula occludens protein)
binding motifs to ZO proteins, to PATJ (PALS1 associated tight junction
protein) and also to MUPP1 (multi-PDZ domain protein-1). Claudins
however, share no sequence homology with occludin. Claudins are the
major components of TJ strands and have a determinant role in the
barrier function. They formparacellular channels,which are selective for
ions through their ﬁrst extracellular loop from neighboring cells [6,7,9].
ZO (Zonula occludens) proteins (ZO-1, 220 kDa; ZO-2, 160 kDa;
ZO-3, 130 kDa) contain protein binding domains (PDZ, SH3, guanylate
kinase homologous domains) and are scaffolding proteins linking TJ
proteins to the actin cytoskeleton, and possibly also linking TJs to AJs.
ZO-1 and ZO-2 bind to occludin and α-catenin, while ZO-3 binds to
p120-catenin in vitro. Phosphorylation of occludin reduces theential roles.
Potential role References
ulin Cell–cell adhesion [6, 189]
Regulation of paracellular permeability
1 Cell–cell adhesion [16]
Regulation of paracellular permeability
PAR-3, Cell–cell adhesion [18]
Regulation of junction assembly
Cell–cell adhesion [189]
, ZO-2, -3,
in
Regulation of junction assembly [6,189]
F-actin, Regulation of junction assembly [6, 189]
Regulation of junction assembly [6,189]
Regulation of junction assembly [6,189]
, myosin Regulation of junction assembly [6,189]
Regulation of junction assembly
and polarization
[190]
Regulation of junction assembly [1]
[1]
0-catenin, Cell–cell adhesion [1,24]
Ena-VASP,
pectrin,
Regulation of junction assembly [1,191]
Lin-7, Regulation of junction assembly [1,191,192]
V-2 (Rho-GEF) Regulation of junction assembly [20]
mocollin,
, keratin5
Regulation of junction assembly [192]
Cell–cell adhesion [33,193]
, ZO-1, Ponsin, Regulation of junction assembly [33,35,191]
atenin complex Regulation of junction assembly [194]
Regulation of junction assembly [32]
tead of the horizontal bars, for more clarity of the table.
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ﬁlaments through their proline rich C-terminal region, whereas ZO-2
associates with the actin binding protein 4.1R. In addition, the three
ZO isoforms associate to form complexes [1,17].
Junctional adhesion molecules (JAM) (32 kDa glycoprotein, 3
isoforms) contain a transmembrane segment, an extracellular domain
encompassing two immunoglobulin-like subdomains, and a short
cytoplasmic tail. JAMs function as cell–cell adhesion molecules
through their extracellular domains, which are capable of homophilic
interaction and can form heterophilic associations with various
ligands such as integrins. In addition, JAMs associate with intracellular
partners such as ZO-1 and the protease-activated receptor PAR-3
[6,7,9].
Numerous other proteins are involved in TJs: tricellulin, a tetraspan
protein; coxsackie and adenovirus receptor (CAR); endothelial cell-
selective adhesion molecule (ESAM); JAM4; AF-6/afadin; PAR-3;
MUPP-1; cingulin; PILT (protein incorporated later into TJ); and JEAP
(junction-enriched and -associated protein). This results in a complex
TJ organization. The assembly of junctional adhesion proteins through
homophilic and heterophilic interactions is mediated by speciﬁc
domain-binding motifs. For example, JAM-A, JAM-B and JAM-C
contain a class II PDZ domain-binding motif and directly interact
with ZO-1 and PAR-3, whereas CAR, has a class I PDZ domain-binding
motif at its C-terminus and associates with Ligand-of-Numb protein
X1. Epithelial CAR mediates heterophilic interaction with JAM-like
molecules, thereby modulating neutrophil migration as well as the
attachment and entry of group B coxsackie viruses [7,18].
3. Adherens junctions
AJs result from the complex association of multiple components
(Table 1) and play a pivotal role in the initiation of intercellular
contacts between neighboring cells and in stabilizing adhesion.
Moreover, AJs are multifunctional structures involved in the control
of the actin cytoskeleton, focal adhesion, intracellular signaling, and
transcription regulation.
Cadherins (120 kDa) contain only one transmembrane segment
and ﬁve extracellular repeat domains, which mediate Ca++-depen-
dent cell adhesion via homophilic interactions between adjacent cells.
Among the isoforms E- (epithelial), VE- (vascular endothelia)
cadherin, N- (neural), P- (placental), and R- (retina) cadherins, E-
cadherin is the major type distributed in epithelial tissues and VE-
cadherin is speciﬁcally expressed in endothelial cells [1,8,17,19].
The C-terminal cytoplasmic domain of E-cadherin interacts with
proteins, which controls E-cadherin regulation (endocytosis, recycling
and degradation) as well as E-cadherin-mediated intracellular
signaling, gene transcription, and local actin cytoskeleton organiza-
tion. It contains a juxtamembrane domain (JMD) that interacts with
p120-catenin and Hakai, an E3-ubiquitin ligase, and a catenin binding
domain (CBD) for β-catenin [20,24].
E-cadherin has an important role in cell–cell adhesion as well as in
the stabilization of epithelial cell phenotype. Decreased cadherin
function induces disassembly of cell–cell adhesion and disturbs
cadherin-mediated signaling, while leading to de-differentiation
from an epithelial to a mesenchymal phenotype, as well as to an
increased cell migration characteristic of invasive tumor cells [25].
Catenins mediate the interplay between a cadherin complex and
the actin cytoskeleton, and also govern several signaling pathways
that control morphogenesis and tissue homeostasis.
β-Catenin (88 kDa) is characterized by 13 repeats of the armadillo
domain, which consists in a tripleα-helix of 42 amino acids. β-Catenin
binds to the C-terminal part of E-cadherin when phosphorylated on
three serine residues (Ser684, Ser686, Ser692) by CKII (casein kinase)
or GSK-3β (glycogen synthase kinase). In contrast, tyrosine phos-
phorylation (Tyr489 or Tyr654) of β-catenin by Src, Abl, or EGF
receptor prevents the binding to E-cadherin [9,11]. In addition,phosphorylation of β-catenin at Tyr142 by Fer/Fyn, tyrosine kinases
constitutively bound to p120-catenin and activated by Yes kinase,
decreases the association between α- and β-catenin [26,27]. β-Catenin
also binds to α-catenin in a mutual exclusive manner (see below).
Plakoglobin (or γ-catenin), which is homologous to β-catenin, is also
able to bind toα-catenin and cadherin, but its role in AJs is still not fully
understood [1,28].
α-Catenin (102 kDa) is homologous to vinculin, an actin-binding
protein. α-Catenin contains three vinculin homology domains and
differs considerably in sequence from the other catenins [11].α-Catenin
exists both as monomers and dimers. Recently, it has been shown that
monomericα-catenin binds to β-catenin and not to actin, and inversely
dimericα-catenin associateswithactinﬁlamentsbutnotwithβ-catenin
(reviewed in [17,29]). In addition actinﬁlaments bound toα-catenin can
no longer associate with the Arp2–3 complex. Thus, α-catenin
dimerization,whichoccurs athigh concentrationsofα-cateninprobably
in membrane at cell–cell contacts, where cadherin–catenin complexes
are clustered, inhibits Arp2–3 and in so doing switches the actin
polymerization from a branched structure such as is characteristic of
lamellipodia, to bundled actin cables [17,30]. Moreover,α-catenin binds
to other actin-binding proteins: ZO-1, a linker between AJ and TJ
structures; Ena-VASP (enabled, vasodilatation stimulated phosphopro-
tein)whichpromotes actinpolymerization; formin-1, an actin nucleator
of unbranched actin ﬁlaments, afadin (see below); zyxin; spectrin
[11,31]; and EPLIN (epithelial protein lost in neoplasm) [32]. But, the
exact role of each protein in the control of actin polymerization at AJs
remains to be determined.
p120-catenin (120 kDa, 4 isoforms) from the armadillo related
proteins, was ﬁrst described as Src substrate. p120 binds to the juxta-
membrane domain of E-cadherin and regulates the transport of E-
cadherin to membrane as well as the stability of AJs [31]. Phosphory-
lated p120 binds to E-cadherinwith high afﬁnity and thus prevents its
endocytosis and degradation, or it increases the recycling of
internalized E-cadherin to membranes [17,31]. In addition, p120
modulates the actin cytoskeleton through inactivation of RhoA and
activation of Rac and Cdc42 (see below) [20]. The role of p120 is
complex and differs according to the cell types, leading to an increase
or a decrease in adhesion activity [1,23].
The nectin–afadin complex is involved in Ca++-independent
intercellular adhesion and plays a role in the organization of AJs and TJs.
Nectin (4 isoforms and several variants) contains a single trans-
membrane domain, an extracellular region containing three immu-
noglobulin-like domains, and a cytoplasmic extension. Nectin binds to
the cytoplasmic C-terminus of afadin through a PDZ domain, and
afadin binds along the side of actin ﬁlaments, but not to ﬁlament
extremities. Nectin–afadin form dimers and nectin molecules from
neighboring cells associate with each other through at least the ﬁrst
immunoglobulin-like domain. In epithelial cells, nectin–afadin are the
ﬁrst complexes, which assemble at the primary cell–cell contacts.
Subsequently they recruit E-cadherin. Independently of nectin–afadin
complexes, E-cadherin–catenin complexes linked to actin ﬁlaments
formmicroclusters and rapidly recruit nectin–afadin molecules. These
primordial junctions fuse and mature in AJs along the basolateral side
of neighboring cells. At the apical side, they recruit JAMs, occludin, and
claudins to form TJs [33,34]. Nectin–afadin and E-cadherin–catenin
complexes are physically and functionally associated by a mechanism
that remains to be elucidated [35].
4. Rho- and Ras-GTPases
Rho proteins belong to the Ras superfamily. They are small (21–
25 kDa) molecules that share structural homology and become
activated only when bound to GTP. They are molecular switches that
regulate various cellular processes including actin dynamics, endocy-
tosis, gene transcription, cell-cycle progression, and differentiation. So
far twenty members have been identiﬁed in the Rho-GTPase family
Table 2
Role of Rho-GTPases in the control of tight junctions (TJ) and adherens junctions (AJ) and functional consequences in cell barrier integrity.
GTPase Mode of
GTPase alteration
Cell model Major effects on TJ/AJ Functional consequences References
RhoA D. active MDCK Increased actin stress ﬁbers Increased paracellular permeability [66]
Alteration of ZO-1 distribution
Redistribution of occludin, ZO-1, claudin-1 and -2, JAM-1 [60]
Increased detergent solubility of ZO-1 and claudin-2
No alteration of AJ protein localization
Disorganization of TJ ultrastructure [59]
Redistribution of ZO-1 and occludin
Increased detergent solubility of ZO-1
No change in detergent solubility of ZO-2 and occludin
Increased actin ﬁlaments at basal and apical sides ND [63]
No change in E-cadherin and β-catenin localization
Accumulation of ZO-1 and occludin at TJs [61]
Increased occludin phosphorylation
No alteration of ZO-1 phosphorylation
D. inactive MDCK Reduction of apical and basolateral actin ﬁlaments Increased paracellular permeability [60]
No change in TJ ultrastructure [59]
No change in ZO-1 and occludin localization
Decreased detergent solubility of ZO-1
No change in detergent solubility of ZO-2 and occludin
Reduction of actin ﬁlaments No change in paracellular
permeability
[72]
Inhibition of LPA-induced actin ﬁlaments
Inhibition of LPA-induced increase of paracellular
permeability
No change in E-cadherin and β-catenin localization ND [63]
D. inactive, C3 Decreased localization of ZO-1 and occludin at TJs [61]
Decreased occludin phosphorylation
No change in E-cadherin distribution
C3 (incativation) Disappearance of ZO-1 and E-cadherin staining [63]
Rho C3 (inactivation) T84 Depolymerization of actin ﬁlaments at the apical side,
but not at the basal side
Increased paracellular permeability [81]
Redistribution of ZO-1
No change in E-cadherin distribution
D. inactive C3 HUVEC Disappearance of actin stress ﬁbers Decreased paracellular permeability [64]
C3 (inactivation) Disappearance of actin stress ﬁbers ND [113]
No change in E-cadherin distribution
EC Disassembly of actin stress ﬁber with focal adhesion Enhanced endothelial barrier
function
[107]
Reduction of actin ﬁlaments
Reorganization of actin ﬁlaments and
tyrosine-phosphorylated proteins to cell–cell
junctions, increased cell surface area, and increased
cell–cell apposition
SCLC Actin cytoskeleton reorganization Increased E-cadherin mediated
cell–cell adhesion
[195]
EDIN, C3, RhoA RNAi HUVEC Disruption of actin stress ﬁbers Increased endothelial permeability [115]
HMEC Formation of microapertures
CNFy (activation) MyEnd, MesEnd,
HDMEC, PAEC
Increased stress ﬁber formation Increased endothelial permeability
(except in MyEnd)
[177]
Redistribution of VE-cadherin
Formation of intercellular gaps (except in MyEnd)
RhoA D. active S180 cells No change in E-cadherin cell–cell
adhesion
[121]
D. inactive
Rac1 D. active MDCK Increased of actin ﬁlaments at cell–cell contacts No change in barrier permeability [66]
Disorganization of TJ ultrastructure Increased paracellular permeability [59]
Alteration of ZO-1 and occludin localization
No change in detergent solubility of ZO-1, ZO-2
and occludin
Redistribution of claudin-1 and -2 [60]
Increased detergent solubility of claudin-1 and -2
Reduction of actin stress ﬁbers
D. inactive Redistribution of claudin-1 and -2, JAM-1 [60]
Reduction of E-cadherin detergent solubility
No change in TJ ultrastructure [59]
No change in ZO-1 and occludin localization
No change in detergent solubility of ZO-1, ZO-2
and occludin
D. active Increased actin ﬁlaments at cell–cell adhesion sites ND [63]
Increased E-cadherin and β-catenin at cell adhesions
Decreased detergent solubility of E-cadherin
Thicker cell–cell contacts on the lateral side (EM)
D. inactive No change in actin ﬁlaments at cell–cell contacts
Decreased E-cadherin and β-catenin at cell adhesions
Increased detergent solubility of E-cadherin
Loose cell–cell contacts on the lateral side (EM)
D. active Recruitment of WAVE2 at cell–cell contact Formation, stabilization, maturation
of E-cadherin-mediated adhesion
[134]
D. inactive Actin reorganization at cell–cell contacts
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Table 2 (continued)
GTPase Mode of
GTPase alteration
Cell model Major effects on TJ/AJ Functional consequences References
Rac1 D. active Keratinocytes Disassembly of E-cadherin cell–cell
adhesion
[120]
Rac1 D. active Keratinocytes
HUVEC
Establishment of E-cadherin
cell–cell
adhesion
[103,104]
D. inactive
Rho D. active
C3 (inactivation)
Rac1 D. active HUVEC No change in ZO-1 distribution Increased paracellular permeability [64]
D. inactive Redistribution of E-cadherin, β-catenin, ZO-1
Disassembly of TJ and AJ ultrastructure
Rac, Ras LT82 (inactivation) Redistribution of E-cadherin ND [113]
Rac LT 82 (inactivation) MyEnd intact
vessels
Depolymerization of actin ﬁlaments Increased endothelial permeability [174,175]
Redistribution of E-cadherin and β-catenin
Reduction of E-cadherin adhesion
Rac1 D. active S180 cells Reduced E-cadherin-mediated
cell–cell adhesion
[121]
D. inactive
Cdc42 D. active
D. inactive
Cdc42 D. active MDCK Decreased localization of occludin, ZO-1, claudin-1
and -2, JAM-1 at TJs
Increased paracellular permeability [60]
Increased detergent solubility of claudin-1 and -2
D. inactive Redistribution of claudin-2
D. active Thickening and disorganization of cortical actin [74]
Irregular distribution of ZO-1 and occludin
D. inactive Thickening and disorganization of cortical actin
No change in ZO-1 and occludin distribution
D. active No change in actin ﬁlaments at cell–cell contacts ND [63]
D. inactive No change in E-cadherin and β-catenin localization
D. active HMEC1, HPAEC Inhibition of interaction between α- and β-catenin Increased endothelial permeability [126]
D. inactive HUVEC No alteration of actin ﬁlaments and AJ proteins No change in paracellular permeability [64]
Rac, Cdc42 Rho-GDI MDCK Rho-GDI a negative regulator of Rho, Rac, and Cdc42
alters E-cadherin cell–cell adhesion
Maintenance of E-cadherin
cell–cell adhesion
[118]
Reversion by co-transfection of Rho-GDI with D. active
Rac or Cdc42, but not Rho
Rho, Rac,
Cdc42
ToxA, ToxB (inactivation) T84 Depolymerization of actin ﬁlaments at the apical side Increased paracellular permeability [92–94]
Alteration of apical and basal actin ﬁlaments [96]
Redistribution of ZO-1, ZO-2, occludin
No change in E-cadherin distribution
Alteration of TJ ultrastructure
Reduced ZO-1-actin association
ToxB (inactivation) Increased detergent solubility of ZO-1 and occludin
ToxA (inactivation) Redistribution of ZO-1, occludin, claudin-1 [95]
Increased detergent solubility of ZO-1, no change in
ZO-2, occludin, E-cadherin, β-catenin detergent solubility
ToxB (inactivation) MCCD Depolymerization of apical and basal actin ﬁlaments [172]
Increased detergent solubility of E-cadherin
CNF1 (activation) T84 Redistribution of ZO-1, occludin, JAM-1 [102]
Internalization of occludin
No change in E-cadherin, β-catenin distribution
Slight increase in apical actin ﬁlament ring
CNF1 (activation) HUVEC Increased stress ﬁber formation ND [113]
No change in E-cadherin distribution
CNF1 (activation) MesEnd, HDMEC,
PAEC
Increased stress ﬁber formation Increased endothelial permeability
In PAEC
[177]
Redistribution of VE-cadherin in PAEC
Formation of intercellular gaps in PAEC
ToxB (inactivation) MyEnd Reduction of actin ﬁlaments (stress ﬁbers and
junctional actin)
Increased endothelial permeability [114,175]
Redistribution of E-cadherin
Rac, Cdc42 CNF1 (activation) MyEnd Increased junction-associated actin ﬁlaments Enhanced endothelial barrier
function
[177,180]
Translocation of cortactin and VASP to cell junctions
Rac (Cdc42)
Ras
LT82 LT9048
(inactivation)
MCCD Reduction of actin ﬁlaments at basal side but not at
apical side
Increased paracellular permeability [172]
Redistribution of E-cadherin, α- β-catenin
No change in ZO-1, occludin distribution
Increased detergent solubility of E-cadherin
No change in detergent solubility of ZO-1, occludin
EC, bovine pulmonary endothelial cell; HUVEC, human umbilical venous endothelial cells; SCLC, small cell lung carcinoma cell; HDMEC, human dermal microvascular endothelial
cells; HMEC-1 human microvascular endothelial cells, HPAEC, human pulmonary arterial endothelial cells; PAEC, porcine pulmonary artery endothelial cells; MDCK, Madin–Darby
canine kidney cell; MCCD, mouse renal collecting duct cell; MesEnd, mouse mesentery endothelial cell; MyEnd, mouse microvascular endothelial cell; EM, electron microscopy; C3
which inactivates RhoA, RhoB, and RhoC; epithelial differentiation inhibitor (EDIN) which inactivates RhoA, RhoB, and RhoC; LT82, lethal toxin from C. sordellii IP82 which inactivates
Rac, Ras, Rap, Ral; LT9048 from C. sordellii VPI9048 which inactivates Rac, Cdc42, Ras and Rap; ToxA and ToxB from C. difﬁcile which inactivates Rho, Rac and Cdc42; CNF1, cytotoxic
necrotizing factor from E. coli which activates Rho, Rac and Cdc42. CNFy, cytotoxic necrotizing factor from Yersinia pseudotuberculosis; VASP, vasodilatator-stimulated
phosphoprotein; RNAi, RNA interference; ND, not determined. The horizontal bars of the submitted table have been omitted. Please insert a space line instead of the horizontal bars,
for more clarity of the table.
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stress ﬁbers and focal adhesion formation, and Rac and Cdc42, which
regulate membrane rufﬂing, and ﬁlopodium formation, respectively.
Cycling between active and inactive forms of Rho-GTPases is regulated
by at least three protein classes: 1) the guanine-nucleotide-exchange
factors (GEFs), which promote exchange of bound GDP for GTP in
response to extracellular signal(s); 2) the GTPase-activating proteins
(GAPs), which enhance intrinsically low GTPase activity thereby
inactivating Rho-GTPases; and 3) the guanine-nucleotide-dissociation
inhibitors (GDIs), which stabilize the GDP, forms, of Rho-GTPases –
therefore inactive – in the cytosol [37–41]. Despite the evident
diversity among GEF, GAP, and GDI molecules, each class shares a
conserved mechanism of action [42]. Activated Rho-GTPases bind to
membrane lipids via isoprenylated cysteines found in a Cys-Aliphatic
residue-Aliphatic residue-X motif within the C-terminus, and then
subsequently interact with their effectors. The conformational
changes between GDP- and GTP-bound forms of Rho are localized
within two surface loops, named switch I and switch II, which play an
important role in GTP catalysis. Switch I of Rho-GTPases is the main
region for interactions with effector molecules. Most Rac/Cdc42
effectors contain a conserved, GTPase-binding consensus site (Cdc42/
Rac Interactive Binding, CRIB), and many Rho effectors possess a N-
terminal Rho effector homology domain (REM) composed of three
leucine-zipper-like motifs. Rho-GTPases effectors are often Ser/Thr
kinase, lipid kinase, lipase, or a scaffold protein [37].
Ras controls cell division and cell differentiation and mutated Ras
is involved in about 30% of human cancers of different origins [2]. In
difference to Rho-GTPases, Ras is permanently bound to the plasma
membrane through farnesyl and palmytoyl residues. Ras proteins also
cycle between a GTP active form and a GDP inactive form regulated by
speciﬁc GEF and GAP proteins. Activated Ras interacts and activates
Raf-kinase, which in turn passes the signal on toMAP kinase pathways
and then on transcriptional factors [43,44]. It has emerged that
extensive cross-talk exist between Ras and Rho GTPase families [37,
38, 44]. A well-characterized cross talk pathway involves activation of
phosphatidylinositide 3-kinase (PI3K) by Ras and subsequent stimu-
lation of the Rac-Rho signaling pathway [40].
Rho/Ras protein activation is under the control of extracellular
factors via membrane receptors such as receptor tyrosine kinases or
G-protein couple receptors. But, Rho-GTPases are also regulated
through the integrity of cell–cell adhesion. Intercellular junctions
are dynamic structures controlled by a complex network of regulation
including Rho-GTPases, which also generate signals involved in
regulation of multiple cellular processes such as cell polarization,
cell segregation, morphogenesis, and tumor invasion. Formation of E-
cadherin or nectin cell–cell contacts activates Rho-GTPases, mainly
Rac and Cdc42, as well as downregulation of Rap1, which play a role in
the organization of AJs and TJs [45–51] (and see below). Inversely,
disassembly of epithelial cell–cell contacts induces Rho activation
leading to an increased actin polymerization through the Rho-kinase
(ROK) pathway [52,53]. Concomitant activation of Rac contributes to
actin polymerization via p21(Rac/Cdc42) activated kinase (PAK) and
gene activation possibly by p38 MAP kinase activation [54,55]. In
addition, disassembly of E-cadherin junctions accompanied by E-
cadherin endocytosis triggers Rap1 activation, and integrin-depen-
dent focal adhesion [51]. This illustrates cross-talk between cadherin-
and integrin-dependent adhesions.
In addition, Rho and Ras proteins are target of bacterial toxins,
which modulate the actin cytoskeleton and intercellular junctions
([56–58] and see below).
5. Rho and TJs
In epithelial cells, TJs are closely associated with the apical actin
cytoskeleton, which plays a crucial role in the regulation of these
junctions by mechanisms including cortical actin contraction andcontrol of interactions between the actin cytoskeleton and certain TJ
components such as occludin and ZO proteins. Rho is a major
regulator of actin polymerization and has been also recognized as an
important regulator of TJ function.
Transfection of dominant negative or constitutively active RhoA in
epithelial cells such as MDCK cells results in alteration of TJ function
consisting in an increase in cell barrier permeability (decrease in
transepithelial resistance (TER) and increase in passage of ﬂuorescent
tracers) (Table 2). Constitutively active RhoA induces a disorganiza-
tion of TJs, resulting in loss and chaotic arrangement of TJ strands (as
observed by freeze fracture electron microscopy) as well as in
discontinuous distribution of occludin, ZO-1, claudin-1 and -2, and
JAM-1. The latter leads in turn to submembranous diffusion of these
proteins away from the membrane at the cell apical side. In contrast,
dominant negative RhoA does not signiﬁcantly modify TJ organization
[59,60]. However, a partial loss of occludin and ZO-1 was observed at
cell–cell contacts of cells transfected with dominant negative Rho by
Gopalakrishnan et al. [61]. In cells transfected with constitutively
active RhoA, actin ﬁlaments are mainly localized in stress ﬁbers at the
base of the cell and form a broader and more diffuse cortical belt
compared to controls [62]. Similar results on actin distribution were
obtained by Takaishi et al. using MDCK cell lines stably expressing
dominant active RhoA mutant [63]. In contrast, dominant negative
RhoA does not signiﬁcantly perturb actin ﬁlament organization [62],
or reduces the actin ﬁlament content at the apical side and the basal
stress ﬁbers [60]. Thus, RhoA controls TJ function even in the absence
of gross abnormalities in TJ organization. RhoA might regulate subtly
actin ﬁlament contraction and, subsequently, the forces pushing TJ
strands between neighboring cells. Alteration of traction and distance
between TJ strands are probably sufﬁcient to modulate the fence
function [59].
RhoA also controls the permeability of endothelial cells. Dominant
negative RhoA prevents thrombin- and histamine-dependent increase
in permeability and decrease in TER. In addition, inhibition of Rho
prevents the effects induced by thrombin and histamine including
assembly of actin stress ﬁbers and disorganization of TJ components
[64].
Various extracellular factors can modulate the activation of Rho.
Indeed, lysophosphatidic acid (LPA) is a well-known effector which
activates signaling cascades through RhoGTPases. LPA binds to a seven
transmembrane G-protein-coupled receptor on endothelial cells. LPA
increases TJ permeability, probably via dissociation of actin ﬁlament
from TJ components [65].
Prostaglandin E2 receptor (EP3β) has been evidenced to regulate
epithelial barrier through RhoA. Ligand activation of this receptor
leads to a RhoA-dependent increase in TER and also, paradoxically, to a
selective increase in paracellular permeability, such as the passage of
mannitol [66]. The signaling pathway leading to Rho activation by
EP3β has not been fully identiﬁed, but might involve an activation of
Rho-GEF. Indeed, a speciﬁc Rho-speciﬁc GEF was found to be
associated to TJs. In MDCK cells, cGEF-H1 from the Dbl family, an
homologue of human GEF-H1, is concentrated at TJs. Over-expression
of cGEF-H1 results in a speciﬁc activation of RhoA and in an increase in
paracellular permeability without apparent change in distribution of
actin ﬁlaments as well as of TJ components such as occludin, ZO-1, and
claudins [67]. Thereby, cGEF-H1 modulates paracellular permeability
through local activation of RhoA without gross disturbance of TJ and
actin ﬁlament structures. GEF-H1 directly binds to cingulin, an adaptor
protein present in TJs, and when bound to cingulin, it no longer
activates RhoA. When TJs are nascent between neighboring cells,
cingulin accumulates at the forming TJs while sequestering GEF-H1
and inhibiting RhoA signaling at cell conﬂuence [6]. This process
contributes to Rho regulation in epithelial cells.
How does Rho control TJ function? Rho is known to interact with
several effectors and to stimulate several signaling pathways. A main
Rho downstream signaling pathway includes Rho-kinase (or ROK,
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phorylates myosin light chain as well as phosphorylates and
inactivates myosin phosphatases, resulting in an increase in bundle
formation and contraction of acto-myosin ﬁlaments (Fig. 1) [36].
Indeed, myosin light chain phosphorylation correlates with increased
TJ permeability induced, for example, by activation of Na+-glucose
cotransport in intestinal CaCo-2 cells, while inhibition of myosin light
chain phosphorylation by speciﬁc inhibitors of myosin light chain
kinase results in the prevention of increased TJ permeability [68]. The
perijunctional actin ring at the apical side of epithelial cells is capable
of generating contractile forces, and thus, controls TJ permeability
[69]. Inhibition of ROK by speciﬁc inhibitor or transfection of a
dominant negative mutant in intestinal epithelial cells increases the
paracellular permeability in parallel with a loss of actin ﬁlament-rich
brush border and a reduced intensity of the perijunctional actin ring,
but without redistribution or disassembly of the TJ complexes. This
further supports the fact that ROK is involved in the regulation of the
apical actin cytoskeleton, which in turn controls TJ function [70]. In
addition, ROK directly phosphorylates LIM-kinase (protein kinase
containing two zing ﬁnger domains separated by two hydrophobic
residues), which is activated and subsequently phosphorylates coﬁlin,
an actin-severing factor that is inactive when phosphorylated. Thus
ROK via LIM-kinase-coﬁlin contributes to the organization of actin
ﬁlaments by preventing actin depolymerization (Fig. 1). Moreover,
moesin from the ERM (ezrin, radixin, and moesin) family, which is
involved in microvilli formation and indirectly in regulation of acto-
myosin contraction, is also a substrate of ROK. (review in [40,71].
However, Rho also controls TJ function by ROK-independent mechan-
isms including phosphorylation of occludin [61,72]. Indeed, dominant
active Rho increases the level of occludin phosphorylation in MDCK
cells [61].Fig.1. Regulation of tight junctions by Rho GTPases. Protein complexes of tight junctions (gre
The main pathway (sky blue) involves activated Rho, which activates ROK leading to actomy
PAK, LIMK thus leading to coﬁlin inactivation by phosphorylation (navy blue pathway). Thi6. Rac/Cdc42 and TJs
Rac and Cdc42 also regulate TJ function in epithelial cells. In fact,
active and negative mutants of Rac increase the permeability of MDCK
cell barrier. Nevertheless, an active mutant of Rac alters the TJ
organization as monitored by freeze fracture electron microscopy,
whereas a dominant negative mutant has no effect [62]. Similar
observations of disruption of MDCK barrier function by active and
negative mutants of Rac and Cdc42 have been done by Bruewer et al.,
but with differential effects on TJ organization [60] (Table 2). Active
mutant of Cdc42 causes a redistribution of TJ proteins (ZO-1, claudin-
1, claudin-2, JAM-1) as visualized by a decreased immunoﬂuorescence
staining at cell–cell contacts, albeit to a lesser extent than a negative
mutant of Rho, whereas an active mutant of Rac partially alters the
localization of only claudin-1 and -2. A dominant negative mutant of
Rac also causes a redistribution of claudin-1 and -2 in addition to JAM-
1, while a dominant negative mutant of Cdc42 partially alters the
organization of claudin-2 [60].
Since Rho-GTPases are part of a complex interconnected network
of signaling pathways, their effect on intercellular junctions might
reﬂect an imbalance in their activation state rather than an individual
mechanism of each GTPase acting on intercellular junction compo-
nents. Thus, activation of Cdc42 in ﬁbroblasts could promote the
stimulation of Rac and subsequently Rho [73] which, as discussed
above, is an important regulator of TJs. Rac and Cdc42 participate in TJ
function through the control of the actin cytoskeleton. Thickening
and disorganization of cortical actin is indeed observed in epithelial
cells expressing active or negative mutant of Cdc42, respectively [74].
In addition, RhoGTPases are involved in the formation and main-
tenance of epithelial cell polarity, and this might inﬂuence the control
of TJs, which are crucial for the maintenance of cell polarity, byen) are controlled by small GTPases of the Rho family through different pathways (blue).
osin assembly and contraction. Rac and Cdc42 also modify tight junctions by activating
s pathway induces actin ﬁlament stabilization
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baso-lateral domains. Cdc42 has thereby been found to modulate TJ
and polarized membrane protein trafﬁcking by multiple cellular
pathways [74,75].
7. Rho-GTPases and TJs, lessons from toxins
C3 enzyme is commonly used as a speciﬁc inhibitor of Rho. C3 was
ﬁrst identiﬁed from Clostridium botulinum types C and D as an ADP-
ribosyltransferase speciﬁc for Rho protein [76,77]. C3 related proteins
are also produced by other Gram-positive bacteria such as Clostridium
limosum, Bacillus cereus and Staphylococcus aureus [78]. The C3 related
enzyme produced by S. aureus is called epithelial differentiation
inhibitor (EDIN). The EDIN-producing strains of S. aureus (∼7.8% of all
clinical isolates) are preferentially obtained from skin suppurations as
well as other infection sites, versus only 3.7% of S. aureus isolated from
healthy nasal carriers, thus suggesting that EDIN may be a virulence
factor involved in epithelium disorganization [79].
C3 induces cell rounding and destruction of actin ﬁlaments in
epithelial and ﬁbroblast cells, but only a limited disorganization of
cortical actin [80]. In polarized epithelial intestinal T84 cells, C3
profoundly alters the apical actin cytoskeleton and the distribution of
occludin, ZO-1 and claudin-1, while it increases cell barrier perme-
ability [70,81]. C3 microinjected into MDCK cells causes the
disappearance of actin ﬁlaments at cell–cell adhesion sites, as well
as altering formation of TJs [61,63]. In addition, C3 inhibits
association of the ERM family of proteins and vinculin with the
plasma membrane, which are necessary for developing the basal
edge and focal adhesions of cells [82]. Overall, this information
indicates that Rho plays a central role in forming and maintaining
TJs. It is noteworthy that inhibition of Rho by C3 induces a more
drastic effect on TJ organization than the speciﬁc inhibitor of ROK,
indicating that Rho controls TJ and apical actin via other downstream
effectors. Indeed, ROK does not alter the distribution of AJ molecules,
it mainly regulates TJs by modifying their interaction with actin
ﬁlaments [70].
The glucosylating toxins produced by various clostridial species,
also known as the large clostridial toxins, are 250–300 kDa single-
chain proteins that include Clostridium difﬁcile toxins A (ToxA) and B
(ToxB), Clostridium sordellii lethal toxin (LT) and hemorrhagic toxin
(HT), as well as Clostridium novyi α toxin (α-novyi) [83]. Glucosylat-
ing toxins represent the main virulence factors of these Clostridium
species, commonly involved in intestinal diseases and/or myonecro-
sis. C. difﬁcile can cause pseudomembranous colitis and enteritis that
often follow antibiotic treatment and which represent the most
prevalent nosocomial form of diarrheal disease in hospitals. C. sordellii
and C. novyi both appear as common causative agents of gas gangrene
in humans and animals and C. sordellii is also responsible for dramatic
and non-traumatic toxic shock syndrome subsequently to medical
abortion [84–87]. Additionally, C. sordellii is involved in hemorrhagic
enteritis of cattle as well as enterotoxemia in sheep, and C. novyi can
induce bovine hepatotoxemia [88].
Large clostridial toxins catalyze the glucosylation of Rho and Ras
family proteins using UDP-glucose, with an exception being α-novyi
which utilizes UDP-N-acetylglucosamine as co-substrate. These
enzymes transfer one molecule of glucose or N-acetylglucosamine to
the hydroxyl group of an acceptor amino acid, such as Thr37 of Rho or
Thr35 of Rac, Cdc42, and Ras proteins [89,90]. ToxA and ToxB
glucosylate Rho, Rac, and Cdc42, whereas LT modiﬁes Rac, Cdc42,
and several Ras proteins (i.e., Ras, Rap, Ral). ToxB induces loss of actin
stress ﬁbers and reorganization of focal adhesions accompanied by
cytoplasmic retraction and cell rounding, whereas long protrusions
radiating around the cell yield a particular “actinomorphic” morphol-
ogy [91]. ToxA and α-novyi cause similar cell alterations, but LT
produces cell rounding without branched, membrane protrusions. In
contrast to C3, large clostridial toxins modify more than one GTPasethat renders more difﬁcult the interpretation of cellular effects. Such
effects could be linked to the simultaneous inhibition of several
GTPase pathways and/or activities other than GTPase glucosylation
attributed to the large clostridial toxins.
ToxA and ToxB alter the barrier function of polarized intestinal cells
such as CaCo-2 and T84 cells by increasing paracellular permeability
[92–94]. Concomitant with the permeability increase, ToxA and ToxB
disrupt apical and basal actin ﬁlaments with a subsequent disorga-
nization of the ultrastructure and component distribution (i.e., ZO-1,
ZO-2, occludin, claudin) within TJs. ToxB decreases actin-ZO-1
association and disperses ZO-1 and occludin from lipid-rich mem-
brane microdomains, without changing the occludin phosphorylation
status [95,96]. Since Rho plays an important role in TJ assembly, the
effects of ToxB and ToxA on TJs presumably result from Rho
glucosylation [59]. However, ToxA induces protein kinase C (PKC)
activation independently of GTPasemodiﬁcation, which could account
for altered TJs and increased paracellular permeability [95]. In
addition, ToxA induces pro-inﬂammatory cytokine release, caspase
activation, and apoptosis in T84 cells in a Rho-dependent manner,
which taken together likely contribute to mucosal damage [97].
The cytotoxic necrotizing factor (CNF) is produced by some
pathogenic strains of Escherichia coli. CNF1 (110 kDa) is synthesized
by human strains mainly isolated from urinary tract infections and
neonatal meningitis [98]. CNF1 preferentially targets Rho and
catalyzes deamidation of Gln63 to Glu, but Rac and Cdc42 are also
modiﬁed at an equivalent residue (Gln61). Gln63 (Gln61) is located
within switch II of the Rho-GTPases and has a pivotal role in intrinsic
and GAP-stimulated GTPase activity. Deamidation of Gln63 (Gln61)
into Glu impairs binding of a water molecule required for GTP
hydrolysis [99,100]. Therefore, CNF1 locks Rho-GTPases into a
biologically active form linked to GTP.
In cultured cells, CNF1 converts Rho-GTPases into active forms
that stimulate downstream signaling pathways leading to multi-
nucleation, increased actin polymerization, reorganization of stress
ﬁbers, membrane rufﬂes, increased phagocytic activity among
human epithelial cells, as well as modiﬁcation of intercellular
junctions. The Rho-Glu63 and Rac-Glu61 forms activate phosphati-
dylinositol 1-4 phosphate 5-kinase (PI4P5K), a subsequent increase
of PIP2 levels enhances actin polymerizaton, and activated ROK
stimulates bundling of the actomyosin ﬁlaments. One of the primary
CNF-induced disturbances involves modiﬁcation of intestinal or
urinary tract cell barriers. In intestinal cell monolayers, CNF1
decreases TER and enhances paracellular permeability from the
basal to apical surface. In T84 cell monolayers, CNF1 induces
profound alterations of TJ components. Occludin, ZO-1, claudin-1,
and JAMs are highly redistributed from the apical ring to the
cytoplasm, leading to a complete disruption of the continuity of TJ
integrity between neighboring cells. Total amounts of occludin and
ZO-1 are unchanged following CNF1 treatment. TJ proteins are not
degraded through the late endosome/lysosome pathway but are
probably recycled via membranous structures resembling caveolae/
endosomes, early and recycling endosomes. Caveolae are considered
as special lipid microdomains containing caveolin-1 in plasma
membrane or in endocytic organelles, termed caveosomes [101].
At least a pool of occludin is recycled through the Rab11 recycling
endosomes. In addition, microvillus F-actin and its binding protein,
villin, disappear. In this way, an excessive stimulation of Rho-
GTPases induces alteration of TJ structure and function. CNF1 effects
on TJs could be mainly mediated by Rho activation. However,
inhibitors of Rho or myosin light chain kinase do not prevent the
CNF1 effects, indicating that Rho and subsequent acto-myosin
ﬁlament reorganization are not the only pathways involved in
CNF1 treated cells. TJ alteration by CNF1 through simultaneous
activation of Rho, Rac and Cdc42 illustrates the cooperation of these
GTPases and the complexity of the regulation network of inter-
cellular junctions [102].
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Rho plays a role in the formation of AJs. Indeed, Rho, in addition to
Rac, is required for the establishment of cadherin-mediated cell–cell
adhesion [103]. In keratinocytes, Rho signaling modulates the
organization/clustering of E-cadherin receptors, since inhibition of
Rho removes E-cadherin from AJs. However, in endothelial cells, VE-
cadherin localization is insensitive to Rho [104]. Rho might be
involved in the clustering of cadherin and/or the recruitment of
cytoplasmic proteins to sites of cell–cell contacts. Furthermore it could
regulate the formation of acto-myosin ﬁlaments which stabilize
adhesion between neighboring cells, and/or it could participate in
the development of polarized epithelial phenotype [105]. However, in
conﬂuent MDCK cells, constitutively active and dominant negative
forms of Rho do not affect the distribution of AJ proteins [60].
The role of Rho in the regulation of the endothelial barrier is
controversial. In cultured endothelial cells, RhoA has been implicated
in the control of barrier permeability. Inhibitors of RhoA or ROK have
been shown to prevent the increase in permeability induced by
thrombin [64,106–110]. LPA [111], or histamin [64]. In contrast,
activation or inhibition of Rho do not modify the distribution of VE-
cadherin and do not prevent the permeability induced by thrombin in
HUVEC cells despite a reorganization of actin ﬁlaments [112,113].
Similarly, inhibition of ROK in intact microvessels does not modify the
increased permeability in response to bradykinin or platelet activating
factor [114]. The actin/myosin contractile structure under the control
of Rho/ROK pathway seems to be more important for the barrier
maintenance of cultured endothelial cells than for that of intact
microvessels, which are exposed to distending forces of blood
pressure and in which tethering mechanisms at cell–cell contacts
may be more critical [114]. But differences might exist in signaling
pathways between the different types of microvessel. Indeed, the
prolonged hyperpermeability induced by thrombin in rat kidney
arterioles was found to be mainly mediated by Rho/ROK-dependent
contractile response [109].
The level of Rho inactivation is critical for its effect on the
endothelial barrier function, protection or alteration, and might
explain the opposite results from the literature (Table 2). A higher
level of Rho inactivation than that required to prevent thrombin-
dependent hyperpermeability in HUVEC by EDIN or Rho RNA
interference induces transient macroapertures and increased perme-
ability. This process is associated with a loss of actin stress ﬁbers and
ROK inactivation, and constitutes an additional mechanism of
alteration of cell barrier integrity, in this case involving tunnel
formation through endothelial cells instead of intercellular gaps
[115,116].
The mechanism of Rho-dependent control of AJs seems to involve
two opposing pathways. The ROK pathway, which generates con-
tractile forces, leads to AJ disruption, whereas the Dia (a Rho effector)
signaling promotes actin polymerization and stabilization of E-
cadherin–catenin complexes, probably through mediating their
association to the cortical actin cytoskeleton. These two mechanisms
might be coordinated by the levels of active Rho, with low levels of
active Rho favoring signaling through Dia and thus stabilizing AJs, and
high levels leading to ROK signaling and AJ disruption [117].
9. Rac/Cdc42 and AJs
Studies with active and negative mutants of Rac and Cdc42
indicate that these RhoGTPases control the formation and main-
tenance of cadherin-mediated intercellular junctions (Table 2).
Microinjection of negative mutant of Rac inhibits the accumulation
of E-cadherin at cell–cell contacts in keratinocytes [104], as well as in
MDCK cells [63], whereas overexpression of active Rac induces the
accumulation of E-cadherin, β-catenin and actin ﬁlaments at sites of
MDCK cell–cell contacts [63].Rac and Cdc42 are required for maintaining cell–cell adhesion
[118,119]. However, Rac seems to have a major role in controlling AJs,
since Rac activation is sufﬁcient to disassemble cadherin-dependent
intercellular junctions in keratinocytes [120]. In conﬂuent MDCK cells
with mature cell–cell junctions, dominant negative Rac increases the
E-cadherin distribution from detergent-insoluble to detergent-soluble
fractions, whereas the partition of TJ proteins (occludin, ZO-1) is
unaffected [60], further supporting the speciﬁc role of Rac in AJ control
versus TJ.
Strength of E-cadherin-dependent cell–cell adhesion has been
quantiﬁed in a cell–cell assay. The actin cytoskeleton and Rho-GTPases
are not involved in the initial phase (up to 30 s) of homophilic
interaction of E-cadherin extracellular domains. However, a subse-
quent activation of Rac and Cdc42, but not Rho, is required for the
development and strengthening of E-cadherin-mediated adhesion.
This clearly demonstrates the major role of Rac and Cdc42, but not
Rho, in the control of E-cadherin-dependent junctions [121,122].
Rac is also an important regulator of endothelial permeability.
Dominant negative or active mutants of Rac increase the permeability
in HUVEC, although the two mutants have opposing effects on stress
ﬁbers. The two mutants induce alterations of AJs and TJs resulting in
intercellular gaps. In addition, dominant negative Rac prevents actin
ﬁlament reorganization and VE-cadherin redistribution from mem-
brane to cytoplasm induced by thrombin and histamin in endothelial
cells [64]. Increased permeability and alteration of endothelial
junctions in response to thrombin stimulation seem to involve down
regulation of Rac as well as Rho activation [14,112]. However, the role
of Rac in thrombin-stimulated cells was not evidenced by van Nieuw
Amerongen et al., who show that the thrombin-dependent hyperper-
meability in HUVEC is associated with an acto-myosin contractile
response mediated by activation of the Rho/ROK pathway [110]. In
contrast, dominant negative Cdc42 does not increase permeability of
HUVEC endothelial cells, although this mutant reduces thrombin-
induced stress ﬁber formation and actomyosin contractility [64,123].
Cdc42 might contribute to the increased cell contractility subsequent
to thrombin treatment through Rho activation or/and in a Rho-
independent manner via activation of PAK and myotonic-dystrophy
related kinases (MRCKα), two common effectors of Rac and Cdc42
[64]. Thereby, control of both actomyosin ﬁlaments and of the
organization of structural intercellular junction components is critical
for endothelial permeability.
In contrast to histamin and thrombin which increase endothelial
permeability, other compounds such as sphingosine 1-phosphate (S1-
P) reinforce the endothelial barrier function. S1-P mainly activates
Rac, and weakly in a delayed manner Rho, resulting in a PAK-LIM
kinase pathway, subsequent inactivation of coﬁlin, and accumulation
of cortical actin ﬁlaments [124,125]. This further supports the critical
role of Rac in the control of endothelial barrier function.
Disassembly of AJs, where phosphorylation and subsequent
dissociation of VE-cadherin and catenins are usual mechanisms,
triggers a speciﬁc activation of Cdc42 which plays an essential role in
the restoration of endothelial barrier integrity [126–128]. Activated
Cdc42, and to a lesser extent Rac1, translocate from the cytosol to the
membrane during the period of AJ restoration [127,129]. After loss of
homotypic VE-cadherin interactions, the cytoplasmic domain of VE-
cadherin is responsible for Cdc42 activation, by a yet unknown
pathway, which might involve activation of a Cdc42-speciﬁc GEF.
Another mechanism could be an activation of a Rho-GAP such as
p190RhoGAP, which is recruited to disassemble AJs by its interaction
with p120-catenin, leading to local Rho inactivation and subsequent
Cdc42 activation [128,130]. Therefore, AJ disassembly regulates Cdc42
which in its turn controls AJ restoration. A model has been proposed
for the thrombin-dependent increase and subsequent recovery of
endothelial barrier function. Thrombin, through activation of PAR-1
and subsequently of Gαq and Gα12/13 heterotrimeric G proteins,
rapidly (less than 1 h) activates Rho, leading to contraction of acto-
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permeability. A delayed activation of Cdc42 parallels the endothelial
barrier repair [130,131]. The mechanism of Cdc42-dependent rean-
nealing of AJs is still speculative. Cdc42 promotes the association of
VE-cadherin with α-catenins, and homotypic adhesion of VE-
cadherin, possibly through IQGAP1 (see below) and actin remodeling
via WASP (Wiskott–Aldrich syndrome protein) [130].
One mechanism of AJ control by Rac and Cdc42 includes the
regulation of local actin cytoskeleton. Active Cdc42 interacts with
WASP and stimulates Arp2/3-dependent actin polymerization, which
is involved in ﬁlopodia formation, whereas Rac associates withWAVEs
(Wasp family verprolin homologous proteins) and IRSp53 (protein
containing a I-BAR domain, Inverse-bin-Amphiphysins-R) to activate
the Arp2/3 complex and to promote membrane protrusions such as
lamellipodia and rufﬂes [132]. Two types of actin population have
been identiﬁed at cell–cell contacts, a more stable actin population
resulting from reorganization of pre-existing actin ﬁlaments, termed
thin bundles, and a dynamic population termed, junctional actin and
consisting in de novo actin polymerization [133]. Rac, through the
WAVE2-Arp2/3 pathway, which stimulates junctional actin polymer-
ization, was found to have amajor role in promoting cell–cell contacts,
as well as in stabilization and maturation of E-cadherin-mediated
cell–cell adhesion [134]. In addition, a cross talk between Rho-GTPases
is involved in the control of AJs. A recent study shows that expression
of dominant active Cdc42 in vascular endothelial cells in vivo protects
the cell barrier integrity by preventing the Rho-dependent hyperper-
meability effects [135].
In contrast to Rho, Rac and Cdc42 directly act on the activity and
assembly of the cadherin–catenin complex (Fig. 2) [136]. IQGAP1 is aFig. 2. Regulation of adherens junctions by Rho GTPases. Rac and Cdc42 are the main regu
inactivation by its phosphorylation and, thus actin ﬁlament stabilization (navy blue pathw
(yellow, see text). Activated Rho has a dual effect, stabilizing adherens junction via Dia and
activation and MLC phosphorylation (sky blue pathway). Activated Rac also contributes to c
cytoskeleton through a pathway comprising WASP or WAVE and Arp2/3 complex.common effector of Rac and Cdc42, and has been shown to interact
with β-catenin and the cytoplasmic domain of E-cadherin. A model
has been proposed in which Rac and Cdc42 regulate cadherin
junctions through IQGAP1. Active Rac and Cdc42 in the GTP-bound
form interact with IQGAP1 and thus prevent the association of IQGAP1
with β-catenin, which results in the stabilization of cadherin–catenin
complex. In the GDP-bound form, non-active Rac and Cdc42 do not
interact with IQGAP1, which associates with β-catenin, thereby
displacing α-catenin from its binding to β-catenin. This leads to a
dissociation of α-catenin linked to actin ﬁlaments from the cadherin–
catenin complex, conferring a weak adhesive activity [129,136–139].
Further work with knockdown Rac and/or IQGAP1 supports that Rac
positively regulates cell–cell adhesion through IQGAP1 by promoting
the accumulation of actin ﬁlaments, E-cadherin, and β-catenin at
MDCK cell–cell contact sites [140]. In endothelial cells, Cdc42 has been
also shown to promote association of α-catenin with VE-cadherin–β-
catenin complex, but by a non-deﬁned pathway [126]. However, the
exact mode of action of IQGAP1 remains unclear since it has been
found thatα-catenin cannot forma quaternary complexwithβ-catenin,
E-cadherin, and actin ﬁlaments in live cells, and that α-catenin–β-
catenin and α-catenin–actin ﬁlament interactions are mutually exclu-
sive [141]. α-Catenin probably regulates actin ﬁlament assembly by
interacting in a monomeric form with E-cadherin–β-catenin
complex, and in a dimeric form with actin ﬁlaments [142] (and
see above). Rac probably contributes through IQGAP1 to the
maturation of nascent cell–cell contacts to mature AJs and to
maintaining a balance between a dynamic and a more static state
[29,143]. In addition, E-cadherin-mediated intercellular junctions
activate Rac thus permitting the recruitment of actin to cell–celllators of adherens junctions. These GTPases activate PAK, LIMK thus leading to coﬁlin
ay), Rac and Cdc42 also regulate adherens junctions via a pathway involving IQGAP1
proﬁlin (white) or leading to contraction and disruption of cell–cell junctions via ROK
adherin endocytosis and its recycling. Rac and Cdc42 play a role in organization of actin
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cadherin signaling involves phosphatidylinositol 3-kinase (PI3-
kinase) [146,147]. PAK phosphorylation, a Rac effector which
stabilizes actin ﬁlament by inhibiting the LIM-kinase-coﬁlin path-
way [148], as well as Tiam1, an exchange factor of Rac, which is
required for Rac activation and maintenance of cadherin-based
adhesions [148,149]. These dynamic processes between intercellular
junctions and Rho-GTPase signaling participate in the coordinated
assembly and stability of AJs and thus in the regulation of barrier
function (Fig. 2) [45].
Focal adhesion proteins have recently been found to be involved in
the regulation of endothelial AJs in a Rac/Cdc42-dependent manner.
Oxidized phospholipids, which enhance the pulmonary endothelial AJ
function, activate Rac/Cdc42 resulting in a redistribution of focal
adhesion proteins from cytosol to the cell periphery. Focal adhesion
proteins form a novel type of association with AJ complexes via
interactions between paxillin and β-catenin, which is strictly
mediated by Rac and Cdc42 activation. Concomitantly, an enhance-
ment of peripheral actin cytoskeleton has been observed [150]. The
signaling cascade leading to focal adhesion reorganization has not yet
been fully determined. Rac might mediate the phosphorylation of
paxillin at Ser273 and the G protein-coupled receptor kinase-
interacting protein (GIT1) at Ser709 through PAK, thus permitting
the relocalization of the paxillin-GIT1-β-PIX(PAK interacting
exchange factor)-PAK complex to the cell membrane [151,152].
Another mechanism of AJ regulation includes the endocytosis and
protease degradation as well as endocytosis/recycling of cadherin,
which are positively or negatively regulated by Rac/Cdc42, according
to the cell status [21,153–155]. Tyrosine phosphorylated E-cadherin,
possibly by Src or Yes which are enriched in AJs, is ubiquitinated by
Hakai, an E3 ubiquitin ligase, leading to the endocytosis of the E-
cadherin–catenin complex and lysosomal degradation [21]. In MCF-7
breast cancer cells, Cdc42 has been found to trigger E-cadherin
ubiquitination, followed by endocytosis and lysosomal degradation. In
this cell model expressing high levels of E-cadherin, Ca++ depletion
dislocates homophilic interaction resulting in Cdc42 activation.
Activated Cdc42 stimulates EGF receptor signaling leading to Src
activation, tyrosine phosphorylation of E-cadherin, Hakai-dependent
ubiquitination, and lysosomal degradation [156]. A proportion of cell
surface E-cadherin is endocytosed and recycled back to the surface,
and this dynamic process is inﬂuenced by cell–cell contacts. Indeed, in
conﬂuent cells with stable intercellular junctions, only a small pool
of E-cadherin is recycled. Thus, inhibition of E-cadherin endocytosis
by cell–cell contact contributes to AJ stabilization [154]. When cells
do not contact other cells and E-cadherin does not trans-interact, E-
cadherin is continuously endocytosed [157]. E-cadherin–catenin
complex seems to be internalized into non-clathrin vesicles in a
Rac-dependent manner and then recycled [158]. However, both
clathrin and caveolin-dependent mechanisms of E-cadherin endo-
cytosis have been reported [154,158–161]. Only non-transinteract-
ing, but not trans-interacting E-cadherin is endocytosed. Activation
of Rac and Cdc42 by trans-interacting E-cadherin or trans-interact-
ing nectins in stable AJs inhibits E-cadherin endocytosis through
IQGAP1, presumably by a cross-linking activity of actin ﬁlaments at
cell–cell adhesion and thus contributes to strengthening AJs [157].
The effects of Rac on E-cadherin and AJs might depend on the state
of intercellular junction maturity. In subconﬂuent MDCK cells, but
not in conﬂuent cells, activation of Ezrin (from the ERM protein
family) upon phosphorylation induces Rac activation, E-cadherin
internalization, lamellipodia formation and loss of cell–cell contacts
[162].
p120-catenin is involved in the control of AJ functions, and it acts,
at least in part, through the regulation of RhoGTPases. p120-catenin
binding to E-cadherin promotes stabilization of AJ components by an
unknown mechanism and also prevents E-cadherin endocytosis
[20,22]. Binding of p120-catenin to E-cadherin recruits and activatesRac at nascent cell–cell contacts, which through PAK participates in
the reorganization of the actin cytoskeleton and stabilization of AJs
[20]. Cytoplasmic p120-catenin activates both Rac and Cdc42 probably
by stimulation of the Rho-GEF, Vav2 while in contrast down-
regulating Rho [163]. In various cell types, Rho antagonizes Rac and
Cdc42 activation, and reciprocally [164,165]. Activated Rac is recruited
to AJs by binding to p120-catenin which then recruits and activates
p190 GAP, thus inactivating locally Rho [166]. Another possibility is
that p120-catenin binds directly to Rho, and as GDI, prevents GDP
exchange for GTP [167,168]. Binding of p120-catenin to E-cadherin and
its negative regulation of Rho have been shown to be mutually
exclusive, only unbound p120-catenin being able to inhibit Rho
activation [169]. But p120-catenin and/or α-catenin may recruit Rho
to AJs allowing it to be activated by GEF [168]. Cell density possibly
regulates the levels of cytoplasmic and cadherin-bound p120-catenin
and, subsequently, the balance of activated RhoGTPases that control
cell adhesion [170].
10. Rho-GTPases and AJs, lessons from toxins
C. sordellii LT is responsible for myonecrosis and gangrene, which
are characterized by an extensive local edema, as well as for
enterotoxemia, necrotic and hemorrhagic enteritis in animals, and
also for fatal toxic shock syndrome in women. The latter is
accompanied by irreversible hypotension, hemoconcentration, pleural
effusion, and serosanguinous ascites, indicating that this toxin targets
epithelial and endothelial cell barriers [171]. In an epithelial cell
monolayer model of mouse cortical collecting duct (MCCD) cells, C.
sordellii LT82, which inactivates Rac, and LT9048, which inactivates
both Rac and Cdc42 among the Rho-GTPases by UDP-glucosylation,
induce a speciﬁc depolymerization of baso-lateral actin ﬁlaments, an
increased cell barrier permeability, and a drastic perturbation of AJs
(Table 2), whereas apical actin and TJs are preserved. Thereby, LTs
cause a dramatic redistribution of E-cadherin, α- and β-catenins from
the plasma membrane to the cytoplasm, with a reduced and
discontinuous distribution of these molecules at the junctional ring
and a diffuse localization into the cytosol. Simultaneously, E-cadherin
is reduced at the cell surface and is increased in detergent soluble
fraction. LTs remove the whole E-cadherin–catenin complex from the
membrane through a mechanism involving the depolymerization of
cortical actin, but not the Rac-IQGAP pathway. LTs which inactivate
Rac, or Rac/Cdc42, but not Rho, disorganize AJs but not TJs in epithelial
cells or only weakly, further supporting the role of Rac in the control of
AJs [172,173].
LT, which inactivates Rac, is also responsible for alteration of
endothelial cell integrity. In HUVEC endothelial cell monolayers, LT
causes a pronounced disorganization of VE-cadherin, the localization
of which at cell–cell junctions is discontinuous and interrupted by
gaps, and a modest alteration of the actin cytoskeleton [113].
Discontinuous staining of VE-cadherin and β-catenin accompanied
by an increased permeability, was also observed in microvascular
endothelial cell (MyEnd) monolayers treated with LT [174]. In
addition, LT causes a reduced VE-cadherin–cadherin adhesion and a
fragmentation of cortical actin in MyEnd cells. In this cell model, it is
concluded that LT alters VE-cadherin junctions, via inactivation of Rac
and subsequent depolymerization of actin ﬁlaments and disconnec-
tion of VE-cadherin from the actin cytoskeleton [174]. Similarly, LT
increases the permeability in intact venular microvessels. Although LT
alters actin ﬁlaments including acto-myosin stress ﬁbers and cortical
actin, its Rac-mediated effect on increased permeability is not
dependent on the acto-myosin contractile mechanism, but rather on
the dissociation of VE-cadherin from the actin cytoskeleton. Indeed,
inhibitors of myosin contraction do not prevent LT permeability
increase in intact microvessels. However, acto-myosin contraction
which results from the remodeling of a few thick stress ﬁbers after LT
treatment, seems to control permeability in cultured vascular
Fig. 3. Ras and the regulation of tight and adherens junctions. Diagram of relationships
between Ras its effectors involved in the regulation of tight and adherens junctions.
Three main pathways are regulated by Ras. The ﬁrst one involves Raf, MEK1/2 and the
MAPK Erk1/2. The second one acts via activation of PI3K, Rac and Rho. The third one
requires activation of AF-6.
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supports the idea that in intact microvessels Rac controls AJs and
permeability mainly by controlling the anchorage of VE-cadherin to
the actin cytoskeleton independently of the acto-myosin contractile
mechanism [175]. But the state of actin polymerization, depolymer-
ization or hyperpolymerization, is critical for the stability of
endothelial barrier function [176] and Rho-GTPases might have
different effects on barrier function according to the endothelial cell
types [177]. This further indicates that a subset of actin ﬁlaments
regulated by Rac is essential for the organization of VE-cadherin
junctions.
LT is a highly potent lethal toxin but its mechanism of lethality is
still elusive. Intraperitoneal injection of LT in mice induces an
increased vascular permeability, mainly at the level of lung vessels,
leading to a massive extravasation of blood ﬂuid in the thoracic cavity,
dehydration, increase in hematocrit, hypoxia, and ﬁnally a cardio-
respiratory distress. Alterations of lung endothelial cells were
evidenced by electron microscopy showing modiﬁcations of AJs that
appear fainter and more discontinuous than in control. VE-cadherin
immunostaining is markedly altered with an interrupted and locally
diffuse staining reﬂecting a redistribution of VE-cadherin from the
junctional ring to the cytoplasm [171]. Thereby, LT, which inactivates
Rac among the RhoGTPases, seems to preferentially target endothelial
cells in the cardio-respiratory area, to alter the distribution of VE-
cadherin, and subsequently to increase the endothelial barrier
permeability leading to local edema and hemodynamic perturbations
probably responsible for lethality.
ToxA and ToxB modify both TJ and AJ organization as well as apical
and basolateral actin cytoskeleton in epithelial cell monolayers, and
disrupt the epithelial barrier function (see above) [92,93,172]. Since
these toxins simultaneously inactivate Rho, Rac and Cdc42, the toxin
effects of each altered GTPase are difﬁcult to show, and a synergetic
RhoGTPase modiﬁcation leading to disruption of all pools of actin
cytoskeleton and intercellular junctions is observed, comparable to
that induced by toxins, such as cytochalasin and Clostridium perfrin-
gens Iota toxin, which inhibits the actin ﬁlament polymerization by
ADP-ribosylating actin monomers [178]. In an in vivo zebraﬁsh model,
ToxB localizes at the pericardial region and induces a cardiovascular
failure including an extensive pericardial edema. But the potential
effects of ToxB on endothelial intercellular junctions in vivo have not
been investigated [179].
CNF1, as mentioned above, activates Rho, Rac and Cdc42, and
disturbs the epithelial and endothelial barrier permeability. In HUVEC
cells, CNF1 induces a prominent stress ﬁber formation without
signiﬁcant modiﬁcation of the VE-cadherin localization [113].
Although, a higher level of Rac and Cdc42 activation than that of
RhoAwas detected in T84 intestinal cells treated with CNF1, the major
CNF1 effects concern TJs, whereas only subtle alterations of AJs
containing E-cadherin have been observed. Only, a slight increase in E-
cadherin and β-catenin staining at cell–cell contacts has been
observed. Since the CNF1-induced alterations are not blocked by
Rho inhibitors, a delicate balance of Rho activity and interplay
between RhoGTPases must be involved in the maintenance of optimal
organization and function of intercellular junctions [102].
CNF has different effects on endothelial cells according to the
endothelial cell types (Table 2). CNF1 activates RhoA, Rac and Cdc42 in
MesEnd, PAEC and HDMEC cells, but only Rac and Cdc42 in MyEnd
cells, whereas CNFy from Yersinia pseudotuberculosis selectively
activates RhoA in all four endothelial cell lines. RhoA activation
resulting in increased stress ﬁber formation alters the endothelial
barrier integrity only in some endothelial cells such as PAEC. In
combination with the results obtained with toxins inhibiting Rho-
GTPases (LT, ToxB), it is concluded that Rac is the common regulator of
barrier function of the different endothelial cells, even if a complex
regulation system involving the other Rho-GTPases is involved
[117,180].11. Ras and intercellular junctions
Contradictory results have been observed in the effects of activated
Ras on intercellular junctions [181]. Microinjection of activated Ras in
MDCK cells leads to disorganization of AJs, visualized by the loss of E-
cadherin and β-catenin from intercellular junctions, but without
signiﬁcant changes in the distribution of TJ components. These Ras
effects are mediated by two pathways, MEK1 and PI3K-Rac1, as shown
by using speciﬁc inhibitors of MEK1 and PI3K, as well as dominant
negative mutants of MEK1 or Rac1 (Fig. 3). It is noteworthy that both
pathways activated by Ras are required for AJ disassembly [182].
Similar effects on AJ have been observed in epidermal keratinocytes
microinjectedwith activated Ras, which induces the loss of E-cadherin
and α-catenin from the cell–cell contacts as well as a redistribution of
β-catenin to the cytoplasm and nucleus in a PI3K-dependent manner
[183]. In contrast, in MDCK cells transformed with Ras hyperactive
mutant, TJ proteins (ZO-1, occludin and claudin-1) are redistributed
from the intercellular contacts to the cytoplasm, and E-cadherin
expression is decreased. Prevention of Ras effects withMEK1 inhibitor
causes reassembly of TJs, phosphorylation of ZO-1 and occludin, as
well as the restoration of the cell barrier integrity [184]. The
differences in the hyperactive Ras effects on TJs or AJs according to
these studies might depend on the different cell models and levels of
activated Ras resulting from cell transformation or protein micro-
injection. However, these ﬁndings show that Ras does not directly
control TJs and AJs, but uses complex signaling pathways, some of
them involving Rho proteins.
Another Ras-dependent signaling pathway includes afadin (AF-6
for human afadin) (Fig. 3). Afadin contains two Ras-binding domains,
in addition to other protein–protein interacting domains like a DIL
domain, a PDZ domain, three proline-rich domains and an actin
ﬁlament-binding domain [33]. It has been shown that afadin
associates with ZO-1 through the Ras-binding domains, and that
activated Ras prevents the interaction between afadin and ZO-1 in
vitro. In addition, transformation of Rat1 cells with activated Ras
reduces the membrane localization of afadin and ZO-1, and inhibits
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could control intercellular junctions through the afadin target effector.
Another possibility could be that afadin, which only binds to GTP-Ras,
sequesters activated Ras, preventing its interaction with downstream
effectors [181].
Loss of intercellular junctions is a crucial step in tumor progression
such as carcinomas. Oncogenic Ras seems to collaborate with Rho-
GTPases, at least in part by altering cell–cell association, to induce full
malignant activity [3]. For example, oncogenic Ras decreases Rac
activity by downregulation of Tiam1 through the Raf/MAP kinase
signaling, and increases Rho activity, leading to epithelial–mesench-
ymal transition [186]. However, in primary epithelial cells over-
expression of dominant active Ras results in a decrease in cell–cell
adhesion and loss of epithelial morphology through a pathway
including activated Rac. Indeed, co-expression of dominant active
Rac with dominant active Ras enhances the disassembly of AJs by
preventing association of α-catenin with E-cadherin–β-catenin com-
plex [187]. This again highlights the complexity of interplay between
Ras and Rho-GTPases.
12. Concluding remarks
Intercellular junctions are dynamic structures, even after cell–cell
contacts have been stably formed. Structural proteins of AJs and TJs are
continuously recycled between plasma membrane and intracellular
compartments. A strict spatio-temporal regulation of intercellular
junctions is required for the proper functioning of epithelial and
endothelial barriers. Among the complex network of AJ and TJ
regulation, Rho/Ras-GTPases play an important role. Cross talk
between RhoGTPases and intercellular junctions is complex. RhoGT-
Pases are involved in the formation and maintenance of stable
junctions. Conversely, intercellular junctions such as cadherin-
dependent junctions activate various signaling pathways including
RhoGTPases which participate in cell morphology, growth control,
survival, and differentiation [45,46].
Although Rho seems to preferentially regulate TJs, and Rac/Cdc42
mainly control AJs, a ﬁne balance in the activity of all Rho/Ras-GTPases
is required for the appropriate epithelial and endothelial barrier
function. Up- or down-regulation of one GTpase results in breakdown
of barrier functionwith increased permeability. Thus, a complex cross-
talk between Rho/Ras-GTPases is involved in the maintenance of
optimal organization and function of epithelial and endothelial
barriers. Rho acts mainly by controlling through ROK, the contractility
of acto-myosin ﬁlaments, which are linked to TJ and AJ components,
whereas Rac/Cdc42 preferentially promote assembly/disassembly of
AJ components or their associationwith actin ﬁlaments. In endothelial
barriers, where TJs and AJs are intermingled, a strict spatio-temporal
coordination between Rho-GTPases is required to ensure an optimal
barrier function. Such a time-regulated process has been recently
evidenced including Rho activation by an external signal, which leads
to an increased permeability, and including a delayed activation of
cdc42 permitting the restoration of endothelial barrier [150].
Dysfunction of epithelial/endothelial barrier function is a critical
step in the pathogenesis of various diseases. For example, localized
infection can trigger the release of inﬂammatory factors, which
increase cell barrier permeability. Certain pathogens produce toxins,
which impair cell barrier permeability, resulting in alteration of the
intestinal cell barrier and/or vascular endothelial barriers, in forma-
tion of edema, etc. Interestingly, most of the toxins active on
intercellular junctions target Rho/Ras-GTPases, which have a key
role in the regulation of TJs and AJs. Modulation of Rho-GTPase activity
by toxins, for example CNF1-dependent Rho-GTPase activation
followed by inactivation through the ubiquitin–proteasome pathway,
contributes to successful epithelium invasion by bacteria [188]. In
addition, disruption of endothelial barrier is critical in vascular and
lung diseases (atherosclerosis, acute lung injury, etc.). Loss ofintercellular junctions is also a determinant in tumor cell progression
and malignant behavior. Better understanding of the regulation
mechanisms including identiﬁcation of the partners of the regulation
network holds promise for developing new therapeutic strategies
against these diseases.
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